These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV. Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281 [Abstract] [Full Text] [Related]
6. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P, Tarkkanen J, Anttila A. BMJ; 2012 Nov 29; 345():e7789. PubMed ID: 23197596 [Abstract] [Full Text] [Related]
7. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, Granados-García V, Pérez R, Salmerón J. Cancer Causes Control; 2011 Feb 29; 22(2):261-72. PubMed ID: 21170578 [Abstract] [Full Text] [Related]
8. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153 [Abstract] [Full Text] [Related]
10. HPV testing in primary screening of older women. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P. Br J Cancer; 1999 Oct 05; 81(3):554-8. PubMed ID: 10507785 [Abstract] [Full Text] [Related]
11. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284 [Abstract] [Full Text] [Related]
12. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Jan 05; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]
13. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A. BJOG; 2013 Sep 05; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222 [Abstract] [Full Text] [Related]
19. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, Nevarez PH, Acosta RD, Hernández-Avila M. Lancet; 2011 Nov 26; 378(9806):1868-73. PubMed ID: 22051739 [Abstract] [Full Text] [Related]